Bengaluru, Sept. 29 -- The company, known for its presence in the healthcare and pharmaceutical exports market, recently held a board meeting to evaluate a significant investment proposal from an overseas firm. While the offer signals strong confidence in its growth potential, the discussion also centred on maintaining management independence and safeguarding shareholder interests.

Welcure Drugs & Pharmaceuticals Limited's stock, with a market capitalisation of Rs. 67.73 crores, fell to Rs. 5.80, hitting a low of up to 4.5 percent from its previous closing price of Rs. 6.06. Furthermore, the stock over the past year has given a negative return of 21.7 percent.

What Happened?

Welcure Drugs & Pharmaceuticals Ltd. held a board meeting on ...